The Regeneron CEO said its current antibody cocktail anticipated many of the mutations the COVID virus would take, which allowed it to remain effective against the Delta variant.However, the changes that occurred in Omicron outpaced what had been anticipated in the current therapy.As a result, Schleifer asserted that the fight against COVID will last "a long, long time" and will require the constant development of new vaccines and new therapeutics as the virus mutates.

这次变异Omicron有点厉害。再生元的中和抗体都被攻破了。看来疫苗的效果也会暴跌。